Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density

被引:23
作者
Lundstrom, E. [1 ]
Sahlin, L.
Skoog, L.
Hagerstrom, T.
Svane, G.
Azavedo, E.
Sandelin, K.
von Schoultz, B.
机构
[1] Karolinska Univ Hosp, Dept Obstet & Gynecol, SE-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Reprod Endocrinol, SE-17176 Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Pathol & Cytol, SE-17176 Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Radiol, SE-17176 Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Surg, SE-17176 Stockholm, Sweden
关键词
mammographic breast density; breast stroma; proteoclycans; Syndecan-I;
D O I
10.1080/13697130600865741
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To analyze the expression of Syndecan-1 in dense and non-dense human breast tissue. Methods Specimens of histologically normal tissue were obtained from postmenopausal women undergoing surgery for breast cancer. Each tissue block was subject to radiological examination and pair-wise samples of dense and non-dense tissue were collected. Semi-quantitative assessment of immunohistochemical staining intensity for Syndecan-1 and estrogen receptor subtypes was performed. Results The expression of Syndecan-1 in all tissue compartments was significantly higher in dense than in non-dense specimens. The strongest staining was recorded in stromal tissue. There was a strong correlation between epithelial estrogen receptor alpha and stromal cell Syndecan-1 expression in dense tissue (r(s) = 0.7; p = 0.02). This association was absent in non-dense tissue. Conclusion An increase of Syndecan-1 in all tissue compartments and a redistribution from epithelium to stroma may be a characteristic feature for dense breast tissue.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 29 条
[1]   Mammographic density is related to stroma and stromal proteoglycan expression [J].
Alowami, S ;
Troup, S ;
Al-Haddad, S ;
Kirkpatrick, I ;
Watson, PH .
BREAST CANCER RESEARCH, 2003, 5 (05) :R129-R135
[2]  
[Anonymous], REPROD BIOL ENDOCRIN
[3]  
BARBARESCHI M, 2003, CANCER, V1, P474
[4]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[5]   Mammographic breast density as an intermediate phenotype for breast cancer [J].
Boyd, NF ;
Rommens, JM ;
Vogt, K ;
Lee, V ;
Hopper, JL ;
Yaffe, MJ ;
Paterson, AD .
LANCET ONCOLOGY, 2005, 6 (10) :798-808
[6]   Mammographic densities and the prevalence and incidence of histological types of benign breast disease [J].
Boyd, NF ;
Jensen, HM ;
Cooke, G ;
Han, HL ;
Lockwood, GA ;
Miller, AB .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (01) :15-24
[7]   Heritability of mammographic density, a risk factor for breast cancer [J].
Boyd, NF ;
Dite, GS ;
Stone, J ;
Gunasekara, A ;
English, DR ;
McCredie, MRE ;
Giles, GG ;
Tritchler, D ;
Chiarelli, A ;
Yaffe, MJ ;
Hopper, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :886-894
[8]   The association of breast mitogens with mammographic densities [J].
Boyd, NF ;
Stone, J ;
Martin, LJ ;
Jong, R ;
Fishel, E ;
Yaffe, M ;
Hammond, G ;
Minkin, S .
BRITISH JOURNAL OF CANCER, 2002, 87 (08) :876-882
[9]   Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology [J].
Conner, P ;
Söderqvist, G ;
Skoog, L ;
Gräser, T ;
Walter, F ;
Tani, E ;
Carlström, K ;
von Schoultz, B .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (02) :159-165
[10]  
CONNER P, 2004, THESIS KAROLINSKA I